Lexicon Pharmaceuticals (LXRX) Fails to deliver data

Key failure to deliver metrics for Lexicon Pharmaceuticals :

• Last SEC data release: 2026-02-13
• Last 15 days FTD volume: A$0 M
• Last 3 months FTD volume: A$1.16 M
• Last 12 months FTD volume: A$11.71 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Lexicon Pharmaceuticals (LXRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Lexicon Pharmaceuticals (LXRX) - since 2015

Lexicon Pharmaceuticals (LXRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Thermo Fisher Scientific TMO	A$2.14 M	A$69.73 M	🇺🇸 USA
Illumina ILMN	A$8.52 M	A$18.84 M	🇺🇸 USA
Regeneron Pharmaceuticals REGN	A$5.49 M	A$61.3 M	🇺🇸 USA
Ultragenyx Pharmaceutical RARE	A$3.65 M	A$9.29 M	🇺🇸 USA
Ligand Pharmaceuticals LGND	A$4 M	A$12.05 M	🇺🇸 USA
Esperion Therapeutics ESPR	A$3.08 M	A$7.94 M	🇺🇸 USA
Aerie Pharmaceuticals AERI	N/A	A$0.94 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	A$6.81 M	A$14.06 M	🇺🇸 USA
Eterna Therapeutics ERNA	N/A	A$0.08 M	🇺🇸 USA